These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


244 related items for PubMed ID: 2942063

  • 1. The long term effects of percutaneous transluminal angioplasty for treating patients with renovascular hypertension: case studies.
    Ohta H, Takabatake T, Yamamoto Y, Ishida Y, Hara H, Ushiogi Y, Nakamura S, Kawabata M, Hashimoto N, Sasaki T.
    Angiology; 1986 Jul; 37(7):535-42. PubMed ID: 2942063
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia.
    Sos TA, Pickering TG, Sniderman K, Saddekni S, Case DB, Silane MF, Vaughan ED, Laragh JH.
    N Engl J Med; 1983 Aug 04; 309(5):274-9. PubMed ID: 6223227
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous transluminal angioplasty: the treatment of choice for renovascular hypertension due to fibromuscular dysplasia.
    Tegtmeyer CJ, Elson J, Glass TA, Ayers CR, Chevalier RL, Wellons HA, Studdard WE.
    Radiology; 1982 Jun 04; 143(3):631-7. PubMed ID: 6210930
    [Abstract] [Full Text] [Related]

  • 4. Percutaneous transluminal angioplasty improves blood pressure and renal function in renovascular hypertension.
    Bell GM, Reid J, Buist TA.
    Q J Med; 1987 May 04; 63(241):393-403. PubMed ID: 2958895
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Percutaneous angioplasty in clinical management of renovascular hypertension: initial and long-term results.
    Martin LG, Price RB, Casarella WJ, Sones PJ, Wells JO, Zellmer RA, Chuang VP, Silbiger ML, Berkman WA.
    Radiology; 1985 Jun 04; 155(3):629-33. PubMed ID: 3159037
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cure and improvement of renovascular hypertension after percutaneous transluminal angioplasty of renal artery stenosis.
    Greminger P, Steiner A, Schneider E, Kuhlmann U, Steurer J, Siegenthaler W, Vetter W.
    Nephron; 1989 Jun 04; 51(3):362-6. PubMed ID: 2521925
    [Abstract] [Full Text] [Related]

  • 12. Focal renal artery stenosis caused by fibromuscular dysplasia: treatment by percutaneous transluminal angioplasty.
    Archibald GR, Beckmann CF, Libertino JA.
    AJR Am J Roentgenol; 1988 Sep 04; 151(3):593-6. PubMed ID: 2970216
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypertension due to fibromuscular disease in a solitary kidney: treatment by percutaneous transluminal angioplasty.
    Adam A, Winearls CG, Allison DJ.
    Br J Radiol; 1983 Jul 04; 56(667):494-6. PubMed ID: 6222777
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Arterial hypertension with unilateral pressor kidney. Preliminary study, evaluation of the renin index in renal veins, and medical and surgical treatment and percutaneous transluminal angioplasty. Evaluation of the usefulness of captopril].
    Díaz González R, Ruilope Urioste LM, Alcazar de la Osa JM, Mayor Sánchez JJ.
    Actas Urol Esp; 1984 Jul 04; 8(1):3-10. PubMed ID: 6232830
    [No Abstract] [Full Text] [Related]

  • 20. Surgical treatment of renal artery stenosis after failed percutaneous transluminal angioplasty.
    Martinez AG, Novick AC, Hayes JM.
    J Urol; 1990 Nov 04; 144(5):1094-6. PubMed ID: 2146403
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.